David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Cell. 2019 Feb 21;176(5):998-1013.e16. doi: 10.1016/j.cell.2018.12.040. Epub 2019 Jan 31.
Lung cancer is closely associated with chronic inflammation, but the causes of inflammation and the specific immune mediators have not been fully elucidated. The lung is a mucosal tissue colonized by a diverse bacterial community, and pulmonary infections commonly present in lung cancer patients are linked to clinical outcomes. Here, we provide evidence that local microbiota provoke inflammation associated with lung adenocarcinoma by activating lung-resident γδ T cells. Germ-free or antibiotic-treated mice were significantly protected from lung cancer development induced by Kras mutation and p53 loss. Mechanistically, commensal bacteria stimulated Myd88-dependent IL-1β and IL-23 production from myeloid cells, inducing proliferation and activation of Vγ6Vδ1 γδ T cells that produced IL-17 and other effector molecules to promote inflammation and tumor cell proliferation. Our findings clearly link local microbiota-immune crosstalk to lung tumor development and thereby define key cellular and molecular mediators that may serve as effective targets in lung cancer intervention.
肺癌与慢性炎症密切相关,但炎症的原因和特定的免疫介质尚未完全阐明。肺部是一个由多种细菌群落定植的黏膜组织,肺癌患者常见的肺部感染与临床结局相关。在这里,我们提供的证据表明,局部微生物群通过激活肺驻留的 γδ T 细胞引发与肺腺癌相关的炎症。无菌或抗生素处理的小鼠显著免受由 Kras 突变和 p53 缺失引起的肺癌发展的影响。从机制上讲,共生细菌刺激髓样细胞产生依赖 Myd88 的 IL-1β 和 IL-23,诱导 Vγ6Vδ1 γδ T 细胞的增殖和激活,这些细胞产生 IL-17 和其他效应分子,以促进炎症和肿瘤细胞增殖。我们的研究结果清楚地将局部微生物群-免疫相互作用与肺肿瘤的发展联系起来,从而确定了可能作为肺癌干预的有效靶点的关键细胞和分子介质。